Pernix Therapeutics News (NASDAQ:PTX)

Add to My Stocks
$2.49 $0.04 (1.63%) PTX stock closing price Jun 18, 2018 (Closing)
Pernix Therapeutics Announces Sale of Non-Core Product   by Globe Newswire on Nov 06, 2017

PTX Industry Peers

Company Price Change (%)
Versartis (VSAR)2.40.05 (2.04%)
Evoke Pharma (EVOK)2.770.06 (2.21%)
Cumberland Pharma (CPIX)60.01 (0.17%)
Vanda Pharmaceuticals (VNDA)190.25 (1.33%)
Depomed (DEPO)7.190.07 (0.98%)
Eli Lilly (LLY)86.110.77 (0.89%)
Durect (DRRX)2.170.03 (1.36%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Verastem (VSTM)8.582.05 (31.39%)
PTC Therapeutics (PTCT)47.8810.33 (27.51%)
Arrowhead Pharma (ARWR)13.732.66 (24.03%)
Rent-A-Center (RCII)14.682.65 (22.03%)
Nordic American Tankers (NAT)2.620.46 (21.3%)
China Biologic Products (CBPO)99.3917.35 (21.15%)
Park City (PCYG)8.551.35 (18.75%)
Top gainers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Jun 19, 2018
CompanyPriceChange (%)
Catalyst Biosciences (CBIO)9.1116.14 (63.92%)
ZIOPHARM Oncology (ZIOP)3.510.79 (18.37%)
Cytokinetics (CYTK)8.251.65 (16.67%)
Corcept Therapeutics (CORT)16.882.5 (12.9%)
Valeant (VRX)23.563.3 (12.29%)
Baytex Energy (BTE)3.40.46 (11.92%)
Banco Bradesco (BBDO)6.130.75 (10.9%)
Top losers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Jun 19, 2018